A5089543920- Maternal and Perinatal Health Interventions
- Infant Development and Preterm Care
- Opioid Use Disorder Treatment
- Grief, Bereavement, and Mental Health
- Estrogen and related hormone effects
- Maternal Mental Health During Pregnancy and Postpartum
- Maternal and Neonatal Healthcare
- Family and Patient Care in Intensive Care Units
- Child and Adolescent Health
- Child Abuse and Trauma
- Pediatric Pain Management Techniques
- Stress Responses and Cortisol
- Cancer Risks and Factors
- Global Maternal and Child Health
- Child Therapy and Development
- Cardiovascular Issues in Pregnancy
- Pregnancy and preeclampsia studies
- HIV, Drug Use, Sexual Risk
- Financial Literacy, Pension, Retirement Analysis
- Prenatal Substance Exposure Effects
- Healthcare Policy and Management
- Breastfeeding Practices and Influences
- Nursing Roles and Practices
- Colorectal Cancer Treatments and Studies
- Preterm Birth and Chorioamnionitis
University of North Carolina at Chapel Hill
2017-2024
Eli Lilly (United States)
2003-2019
University of North Carolina Health Care
2019
University of Puerto Rico at Carolina
2019
MetroHealth Medical Center
2009
Case Western Reserve University
2009
National Institutes of Health
1999
OBJECTIVE: To evaluate whether the frequency of pain assessment and treatment differed by patient race ethnicity for women after cesarean birth. METHODS: We performed a retrospective cohort study all who underwent birth resulting in liveborn neonate at single institution between July 1, 2014, June 30, 2016. Pain scores documented medications administered delivery were grouped into 0–24 25–48 hours postpartum time periods. Number recorded, any score was 7 10 or greater, analgesic medication...
Cetuximab, in combination with platinum chemotherapy plus 5-fluoruracil (5-FU), is approved for the first-line treatment of recurrent/metastatic squamous cell carcinoma head and neck (SCCHN). Cetuximab manufactured by ImClone (US commercial cetuximab) potentially results higher systemic exposures than cetuximab Boehringer Ingelheim (BI-manufactured cetuximab). This prospective, randomized, double-blind study compared safety profiles two formulations. Patients previously untreated...
To use systems thinking with diverse system actors to (a) characterize current problems at the intersection of chronic conditions (CCs) and reproductive health (RH) care their determinants, (b) determine necessary for change, (c) document cross-system actions that can improve identified in United States.Data were collected from six groups via online focus groups.This is a qualitative multilevel study using iceberg framework.Data by note-taking recording groups; analysis incorporated...
Women with infants in a neonatal intensive care unit (NICU) encounter multiple challenges following childbirth, including greater burden of chronic disease and increased risk for depression, compared women well infants. At the same time, they are confronted trauma hospitalized infant while also managing their postpartum recovery. Limited research exists describing health needs these women, despite many numbers living this experience daily. This study aimed to better understand NICU 90 days...
The pharmacokinetics and potential drug-drug interactions between cetuximab cisplatin or carboplatin from two studies (JXBA JXBB) were evaluated. These multicenter, open-label phase II trials designed to evaluate the (400 mg m-2 initial dose) (JXBA; 100 m-2) (JXBB; area under curve [AUC] = 5 × min mL-1) with without 5-fluorouracil (5FU) in patients advanced solid tumors. Concentrations of cetuximab, determined using analytical methods. safety tolerability combination was also all treated...
INTRODUCTION: We sought to quantify the prevalence and early postpartum (PP) follow-up for hypertensive disorders of pregnancy among mothers medically fragile infants (MMFI). METHODS: conducted a retrospective cohort study delivering at North Carolina Women's Hospital between 7/1/2014 6/30/2016. defined MMFI as with NICU length stay ≥3 days well babies (MWB) not admitted NICU. ascertained using blood pressures (BP) measured in routine clinical care 20 weeks PP discharge from Electronic...
Data-driven decision-making is a common approach for identifying child maltreatment. However, such strategies must be guided by ethical, equitable, and evaluative frameworks due to their potential bias error. This study analyzes the key features, challenges, research evidence of data-driven strategy known as Birth Match. Interviews with informants across four states indicate that programs share features objectives but they differ regarding match criteria, data integrity processes, responses...
( Obstet Gynecol . 2019;134:1155–1162) Racial disparities in perinatal outcomes have been extensively researched, but discrepancies health care and among black women neonates still remain. One nonobstetric example of racial disparity medical is the inconsistency narcotic pain medication administered to white patients who present with migraines or back emergency departments. The current investigators conducted their study assess whether obstetric given at a tertiary academic center North...
Data-driven approaches to surveillance and decision-making have become an increasingly-common strategy for child welfare agencies in the United States tasked with identifying preventing maltreatment. Scholars family advocates called implementation of such strategies be guided by clear ethical, equitable, evaluative frameworks due potential bias error amplified through automated processes that draw on historical data. The purpose current study was provide a descriptive policy analysis...
INTRODUCTION: Mothers of medically fragile infants (MMFI) must recover from birth while attending to an infant in the neonatal intensive care unit (NICU). We hypothesized that, compared with mothers well babies (MWB), MMFI would have more chronic medical problems and obstetric complications, increasing their need for postpartum follow-up. METHODS: Retrospective cohort study delivering at North Carolina Women's Hospital between 7/1/2014 6/30/2015. defined as a NICU length stay 3 or days MWB...